Omalizumab effectiveness in Asthma COPD overlap: post hoc analysis of PROSPERO study

Patients with asthma and COPD overlap (ACO) are poorly represented in asthma clinical trials. This post hoc analysis of a large, real-world study demonstrates that omalizumab may be beneficial in patients with ACO.

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2BrScA0